Businessinsider.co.za | GSK, CureVac making 'next-generation' vaccines they say can tackle multiple Covid-19 variants at once
Published
The new GSK-CureVac mRNA vaccines will target coronavirus variants and could be available in 2022, if approved.
Full Article